Essential Wellness Pharma Recalls HCG Injections Due to Sterility Concerns
Kalman Health & Wellness is recalling HCG 10,000 Units/mL injections because poor sterile production practices created a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or in this case, a lack of sterility assurance which poses a significant risk of serious adverse health consequences, are rated as Severe (4).
Plain-English summary
Kalman Health & Wellness, Inc. dba Essential Wellness Pharma is recalling HCG 10,000 Units/mL Injection, which is available in various vial and prefilled syringe sizes. The product is prescription-only and was distributed nationwide.
The recall was initiated due to observations associated with poor sterile production practices. These practices resulted in a lack of sterility assurance for the finished drugs. The recall covers all compounded sterile preparations within their expiry dates.
Affected lots include 080615, 081215, 081315, 081415, 1730-081715, 1730-081815, and 1730-081915. Consumers should stop using the product and consult their healthcare provider or pharmacist for guidance on disposal or replacement.
The recalled product
- Product
- HCG 10,000 Units/mL Injection, packaged in a) 1 mL, b) 1.2 mL, c) 1.6 mL, d) 2.0 mL, e) 2.4 mL, f) 3.6 mL, g) 4 mL, h) 4.8 mL vials; and i) 0.1 mL, j) 0. 2 mL, k) 0.3 mL prefilled syringes, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: 080615
- Exp 09/06/2015
- 081215
- Exp 09/12/2015
- 081315
- Exp 09/13/2015
- 081415
- Exp 09/14/2015
- 1730-081715
- Exp 09/17/2015
- 1730-081815
- Exp 09/18/2015
- and 1730-081915
- Exp 09/19/2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Kalman Health & Wellness, Inc. dba Essential Wellness Pharma under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Kalman Health & Wellness, Inc. dba Essential Wellness Pharma
See all →- SevereEssential Wellness Pharma Recalls BIMIX INJ Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereEssential Wellness Pharma Recalls 17-Alpha Hydroxyprogesterone Injections for Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereEssential Wellness Pharma Recalls Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- Severe
- SevereEssential Wellness Pharma Recalls Dexamethasone Ointment Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereAssurance Infusion Recalls HCG Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SeverePerry Drug Recalls HCG Injections Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-12-03
- SevereHealth Innovations Pharmacy Recalls HCG Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFDA Recalls 1-HCG 1000 IU/ML Due to Sterility Concerns
FDA (Drugs) · 2016-06-15
- SevereAssurance Infusion Recalls HCG Injections Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereWestern Drug Recalls HCG Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-12-09